<prompt> Multiple myeloma is treated by all, EXCEPT:LenalidomideBoezomibThalidomideAll of the above  <response>: Relapsed myeloma can be treated with novel agents including lenalidomide andor boezomib. Thalidomide, if not used as initial therapy, can achieve responses in refractory cases. High-dose melphalan and stem cell transplant, if not used earlier, also have activity in patients with refractory disease. Ref: Harrisons principle of internal medicine 17th edition, chapter 106. 